Esperion Therapeutics, Inc.
ESPR
Jodie situation report
Esperion Therapeutics, Inc.'s move is spreading beyond its market group.
No new filing conclusion is available. 12 of 21 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 1 directly disclosed connection is confirming.
- At least 14 of 21 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- IMMX remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 7 of 21 members or fewer.
Who this business touches
The relationships behind ESPR
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
JEFJefferies Financial Group Inc.investeeNov 6, 2025 ▾
“On January 19, 2024, Jefferies gave us notice of its election to exercise the option to purchase additional shares, in full.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ESPR is currently a Leader in the organic co-movement group Healthcare Innovators. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.